Characterizing withdrawal from long-acting injectable buprenorphine: An observational case series

Characterizing withdrawal from long-acting injectable buprenorphine: An observational case series

Introduction: Long-acting injectable buprenorphine (LAIB) products are being increasingly used to treat patients with opioid dependence. Limited data is available on the severity or timespan (time to onset, peak, duration) of withdrawal signs and symptoms following discontinuation of treatment. Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria Hayes, Llewellyn Mills, Gaye Byron, Carolyn Stubley, Eleanor Black, Benjamin T. Trevitt, Andrew A. Somogyi, Arshman Sahid, Nicholas Lintzeris
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Opioid withdrawal
Buprenorphine
Long-acting injectable buprenorphine
Opioid dependence treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724625000125
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items